Genetic treatments could be the key to unlocking some rare diseases. But bringing these medicines to patients involves ...
Gene-editing technologies show great promise for medical treatments and research, with the potential to cure thousands of ...
Scientists have used CRISPR to give the goldenberry a modern makeover, shrinking the plant by about a third and making it ...
Multiple sclerosis (MS) is a chronic neurological disease characterized by nerve damage and consequent impairments in vision, ...
A notable surge in investment activity has emerged around Intellia Therapeutics, with significant share acquisitions by both ...
Environmental antimicrobial resistance is turning rivers, soils, and even the air into hidden highways for "superbugs," ...
Aurora Therapeutics, cofounded by Nobel Prize–winning scientist Jennifer Doudna, plans to use gene editing and a new FDA ...
Zacks Investment Research on MSN
CRISPR Therapeutics AG (CRSP) stock slides as market rises: Facts to know before you trade
CRISPR Therapeutics AG (CRSP) ended the recent trading session at $53.84, demonstrating a -4.54% change from the preceding ...
The startup aims to create a platform for treating extremely rare genetic mutations, armed with CRISPR advances and new regulatory pathways.
Technologies at the Advanced Rodent Transgenics Laboratory include genome editing design and implementation and transgenic ...
If I were to locate the moment AI slop broke through into popular consciousness, I’d pick the video of rabbits bouncing on a ...
Menlo Ventures has made a $16 million bet that the “ baby KJ ” custom CRISPR therapy success story is repeatable. The funding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results